Such enhanced levels of Hsp90 is attributed to having a protective effect (via regulation of HSF-1) from various stress parameters such as hypoxia, ischemia, etc., which the cells encounter under pathologic conditions, and since several oncoproteins are clients of Hsp90, targeting Hsp90 represents a useful anti-cancer approach. The gene discussed is HSP90AA1; the disease is cancer.